Swecure Therapy For Allergy and Inflammatory Diseases Prevention Approved in the United States

Swecure Therapy For Allergy and Inflammatory Diseases Prevention Approved in the United States
Swecure AB, a Swedish biotechnology company focused on new treatment strategies for immunoregulatory diseases like allergy and inflammatory bowel disease (IBD), has recently received a patent approval grant from the United States Patent and Trademark Office. The patent refers to Swecure’s experimental product Swe01. Swe01 was developed as a therapeutic agent against allergies and is

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *